Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · Real-Time Price · USD
0.5855
-0.0245 (-4.02%)
Jun 3, 2026, 4:00 PM EDT - Market closed

Oragenics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
335171352
Market Cap Growth
-39.02%-27.94%-73.23%35.85%-75.41%25.99%
Enterprise Value
-3.33-4.834.1115.773.3527.91
Last Close Price
0.590.7811.08168.90189.18802.80
PS Ratio
---460.6397.07596.77
PB Ratio
0.430.40-21.915.470.981.96
P/TBV Ratio
0.260.20-11.544.000.971.96
EV/Sales Ratio
---418.7225.50320.80
EV/EBITDA Ratio
-0.52----
EV/EBIT Ratio
-0.52----
EV/FCF Ratio
-0.52----
Debt / Equity Ratio
0.010.03-1.550.100.030.02
Net Debt / Equity Ratio
-0.98-0.992.53-1.00-0.83-1.00
Net Debt / EBITDA Ratio
0.630.870.050.150.751.68
Net Debt / FCF Ratio
0.650.880.060.430.701.96
Asset Turnover
-000.000.010.00
Quick Ratio
4.674.730.511.947.1618.87
Current Ratio
5.735.640.872.158.9519.17
Return on Equity (ROE)
-30.44%-243.94%-714.95%-255.36%-72.35%-72.52%
Return on Assets (ROA)
-108.16%-160.03%-327.97%-211.97%-67.09%-67.24%
Return on Invested Capital (ROIC)
-5301.85%-3322.34%-1205.62%-1151.75%-893.39%-1484.85%
Return on Capital Employed (ROCE)
-132.64%-232.05%-714.33%-256.03%-72.20%-71.48%
Buyback Yield / Dilution
-797.06%-877.24%-194.35%-11.97%-3.40%-106.24%
Total Shareholder Return
-797.06%-877.24%-194.35%-11.97%-3.40%-106.24%
SEC Filings: 10-K · 10-Q